WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · SB 146

Legislative bill overview

SB 146 amends Utah's glucagon access and administration laws, likely expanding who can prescribe, distribute, or administer glucagon (an emergency medication for severe hypoglycemia) and under what circumstances. The bill has completed the legislative process and was signed by the Governor on March 26, 2025.

Why is this important

Glucagon access laws directly affect diabetes management and emergency response capabilities. Expanding access can improve survival outcomes during severe low-blood-sugar emergencies, particularly in schools, workplaces, and public settings where trained medical professionals may not be immediately available.

Potential points of contention

  • Liability concerns: Broader authorization to administer glucagon may raise questions about liability protection for non-medical personnel who administer the drug
  • Training requirements: Unclear whether expanded access includes mandatory training standards or if anyone can administer glucagon without certification
  • Prescription scope: Changes to who can prescribe glucagon (pharmacists, nurse practitioners, etc.) may face resistance from traditional medical hierarchy advocates

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.